SCHEMBL10302201

SCHEMBL10302201

C=CCOc1ccc(-c2ccc(COc3ccc(C)c(F)c3F)cc2)c(F)c1F

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.36
LMNA P02545 1/20 0.36
HTR2C P28335 5/20 0.34
HTR2B P41595 3/20 0.34
ALDH1A1 P00352 4/20 0.34
CYP2D6 P10635 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MGAM O43451 4/20 0.34
GAA P10253 4/20 0.34
SI P14410 4/20 0.34
MGAM2 Q2M2H8 4/20 0.34
MRGPRX4 Q96LA9 1/20 0.34
HTR2A P28223 2/20 0.33
FFAR1 O14842 1/20 0.33
BCHE P06276 1/20 0.32
KDM4E B2RXH2 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRB2 P47870 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12740955 0.91 FFAR4 (0.44) FFAR4LMNAHTR2CHTR2BALDH1A1
SCHEMBL12736507 0.91 FFAR4 (0.44) FFAR4LMNAHTR2CHTR2BALDH1A1
SCHEMBL10302202 0.88 FFAR4 (0.35) FFAR4LMNAALDH1A1CYP2D6GAA
SCHEMBL10302203 0.88 CNR2 (0.35) FFAR4LMNAALDH1A1CYP2D6GAA
SCHEMBL14767073 0.86 LMNA (0.40) FFAR4LMNAALDH1A1CYP2D6MEN1
SCHEMBL14766513 0.86 LMNA (0.40) FFAR4LMNAALDH1A1CYP2D6MEN1
SCHEMBL10302254 0.86 FFAR1 (0.38) FFAR4LMNAALDH1A1MEN1KMT2A
SCHEMBL10302309 0.86 MRGPRX4 (0.40) MGAMGAASIMGAM2MRGPRX4
SCHEMBL10302285 0.86 MRGPRX4 (0.41) FFAR4LMNAHTR2CHTR2BALDH1A1
SCHEMBL10301931 0.86 CTSS (0.37) LMNAHTR2CHTR2BALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8216489-B2 Three-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-07-10 US disclosed
US-20110037024-A1 THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2011-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110037024-A1 THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE LEF1, LAS1L, L3MBTL3 FFAR4 1669/4885LMNA 239/4885HTR2C 770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.